Liothyronine Sodium 00093-2180
Product NDC
00093-2180- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 26, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA211510
Need to source Liothyronine Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Liothyronine Sodium | 50 ug/1 |
Drug Class
Triiodothyronine [CS]l-Triiodothyronine [EPC]
Packaging Options(1)
100 TABLET in 1 BOTTLE (0093-2180-01)